Correction to Heregulin 1 drives gefitinibresistant growth and invasion in tamoxifenresistant MCF7 breast cancer cells
Bioportfolio,
Related Biotechnology, Pharmaceutical and Healthcare News After the publication of this work [1], an error was noticed in Fig.